Drug Targets Heart Failure in African Americans

Heart failure is two and a half times more common in African Americans than in whites.
A combination drug may soon become the first prescription medicine approved specifically for African Americans. The medicine, called Bidl, treats heart failure. Trials show the drug works much better than conventional therapies, but some worry the results could perpetuate myths about racial differences. Hear NPR's Snigdha Prakash.





Comments
Discussions for this story are now closed. Please see the Community FAQ for more information.